Proliferation of human non-small-cell lung cancer cell lines: Role of interleukin-6

American Journal of Respiratory Cell and Molecular Biology

Volumn 19, Issue 4, 1998, Pages 606-612

  Bihl, Michel ^b   Tamm, Michael ^b   Nauck, Markus ^b   Wieland, Heinrich ^b   Perruchoud, André P ^b   Roth, Michael ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DIAGNOSTIC AGENT; INTERLEUKIN 6; MESSENGER RNA; PLASMA PROTEIN; THYMIDINE; TRITIUM;

ARTICLE; CELL CULTURE; CELL DIVISION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; NUCLEIC ACID PROBE; PHYSIOLOGY;

ANTIBODIES; ANTISENSE ELEMENTS (GENETICS); BLOOD PROTEINS; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIVISION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNE SYSTEM; INTERLEUKIN-6; LUNG NEOPLASMS; RNA, MESSENGER; THYMIDINE; TRITIUM; TUMOR CELLS, CULTURED;

EID: 0032185816     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.19.4.3247     Document Type: Article

References (34)

1. Akira, S., T. Taga, and T. Kishimoto. 1993. IL-6 in biology and medicine. In Advances in Immunology, Vol. 54. F. J. Dixon, editor. Academic Press, La Jolla, CA. 1-78.
2. May, L. T., J. Grayeb, U. Santhanam, S. B. Tatter, Z. Sthoeger, D. C. Helfgott, N. Chiorazzi, G. Grieninger, and F. B. Sehgal. 1988. Synthesis and secretion of multiple form of β2-interferon/B-cell differentiation factor 2/ hepatocyte-stimulating factor by human fibroblasts and monocytes. J. Biol. Chem. 263:7760-7766.
3. May, L. T., U. Santhanam, S. B. Tatter, D. C. Helfgott, A. Ray, J. Ghrayeb, and G. Sehgal. 1988. Phosphorylation of secreted forms of human β2-interferon/hepatocyte-stimulating factor interleukin-6. Biochem. Biophys. Rex. Commun. 152:1144-1150.
4. Kraft, M., S. Filsinger, K. L. Krammer, D. Kabelitz, G. M. Hansch, and M. Schoels. 1995. Synovial fibroblasts as accessory cells for staphylococcal enterotoxin-mediated T-cell activation. Immunology 85:461-466.
5. Walther, Z., L. T. May, and P. B. Seghal. 1988. Transcriptional regulation of the interferon-β2/B cell differentiation factor BSF-2/hepatocyte stimulatory factor in human fibroblasts by other cytokines. J. Immunol. 140:974-977.
6. Elias, J. A., and V. Lentz. 1990. IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA. J. Immunol. 142:161-166.
7. Van Damme, J., G. Opdenakker, R. J. Simpson. M. R. Rubira, S. Cayphas, A. Vink, A. Billiau, and J. Van Snick. 1987. Identification of the human 26-kD protein, interferon-β2, as a cell hybridoma/plasmacytoma growth factor induced by interleukin-1 and tumor necrosis factor. J. Exp. Med. 165:914-919.
8. Kishimoto, T., T. Taga, and S. Akira. 1994. Cytokine signal transduction. Cell 76:253-262.
9. Aggarwal, B. B., K. Totpal, R. Lapushin, M. M. Chaturverdi, O. M. Pereira-Smith, and J. R. Smith. 1995. Diminished responsiveness of senescent normal human fibroblasts to TNF-dependent proliferation and interleukin production is not due to its effect on the receptors or on the activation of a nuclear factor NF-kappa B. Exp. Cell. Res. 218:381-388.
10. Braquet, P., B. Pignol, T. Maisonnet, and J. M. Mencia-Huerta. 1991. Platelet-activating factor modulates interleukin-6 production by mouse fibroblasts. Int. Arch. Allergy Appl. Immunol. 94:165-166.
11. Roth, M., M. Nauck, S. Yousefi, M. Tamm, K. Blaser, A. P. Perruchoud, and H. U. Simon. 1996. Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin-6 and interleukin-8 in human lung fibroblasts via binding to its functional receptor. J. Exp. Med. 184:191-201.
12. Ziesche, R., M. Roth, B. Papakonstantinou, M. Nauck, W. H. Hörl, M. Kashgarian, and L. H. Block. 1994. A granulocyte inhibitory protein overexpressed in chronic renal disease regulates the expression of interleukin-6 and interleukin-8. Proc. Natl. Acad. Sci. USA 91:301-305.
13. Barut, B., D. Chauhan, H. Uchiyama, and K. C. Anderson. 1993. Interleukin-6 functions as an intracellular growth factor in hairy cell leukemia in vitro. J. Clin. Invest. 92:2346-2352.
14. Klein, B., X.-G. Zhang. M. Jourdan, J. Content, F. Houssiau, and L. Aarden. 1989. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 73:517-526.
15. Fries, K. M. M. E. Felch, and R. P. Phipps. 1994. Interleukin-6 is an autocrine growth factor for murine lung fibroblast subsets. Am. J. Respir. Cell Mol. Biol. 11:522-560.
16. Levy, Y., A. Tsapis, and J. C. Brouet. 1991. Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines. J. Clin. Invest. 88:696-699.
17. Roth, M., M. Nauck, M. Tamm, A. P. Perruchoud, and F. H. Block. 1945. Intracellular interleukin-6 mediates platelet-derived growth factor-induced proliferation of nontransformed cells. Proc. Natl. Acad. Sci. USA 92:1332-1336.
18. Humbert, M., G. Monti, F. Brenot. O. Sitbon, A. Portier, F. Grangeot-Keros, P. Duroux, P. Galanaud, G. Simoneau, and D. Emilie. 1995. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am. J. Respir. Crit. Care Med. 151:1628-1633.
19. Horii, Y., A. Muraguchi, M. Iwano, T. Matsuda, F. Hirayama, H. Yamada, Y. Fujii, K. Dohi, H. Ishikawa, Y. Ohmoto, K. Yoshizaki, T. Hirano, and I. Kishimoto. 1989. Involvement of interleukin-6 in mesangial proliferative glomerulonephritis. J. Immunol. 143:3949-3955.
20. Nabata, T., S. Morimoto, E. Koh, E. Shiraishi, and T. Ogihara. 1990. Interleukin-6 stimulates c-myc expression and proliferation of cultured vascular smooth muscle cells. Biochem. Int. 20:445-453.
21. Yanagawa, H., S. Sone, Y. Takahashi, T. Haku, S. Yano, T. Shinohara, and T. Ogura. 1995. Serum levels of interleukin-6 in patients with lung cancer. Br. J. Cancer 71:1095-1098.
22. Miki, S., M. Iwano, Y. Miki, M. Yamamoto, B. Tang, K. Yokokawa, T. Sonuda, T. Hirano, and T. Kishimoto. 1989. Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett. 250:607-610.
23. Watson, J. M., J. L. Sensintaffar, J. S. Berek, and O. Martinez-Maza. 1990. Constitutive production of interleukin-6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res. 50:6959-6965.
24. Schmitter, D., B. Lauber, B. Fagg, and R. A. Stahel. 1992. Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: interleukin-6 production as a common feature. Int. J. Cancer 51:296-301.
25. Gallo, O., D. Bani, G. Toccafondi, F. Almerigogna, and O. F. Storchi. 1992. Characterization of a novel cell line from pleomorphic adenoma of the parotid gland with myoepithelial phenotype and producing interleukin-6 as an autocrine growth factor. Cancer 70:559-568.
26. Fukumoto, S., T. Matsumoto, S. Harada, I. Fujisaki, M. Kawano, and E. Ogata. 1991. Pheochromocytoma with pyrexia and marked inflammatory signs: a paraneoplastic syndrome with possible relation to interleukin-6 production. J. Clin. Endocrinol. Met. 73:871-881.
27. Van Meir, E., Y. Sawamura, A. C. Diserens, M. F. Hamou, and N. de Tribolet. 1990. Human glioblastoma cells release interleukin 6 in vitro and in vivo. Cancer Res. 50:6683-6688.
28. Borsellino, N., A. Belldegrun, and B. Bonavida. 1995. Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines. Cancer Res. 55:4633-4639.
29. Miles, S. A., A. R. Rezai, J. F. Salazar-Gonzàlez, M. Vander Meyden, R. H. Stevens, D. N. Logan, R. F. Mitsuyasu, T. Taga, T. Hirano, T. Kishimoto, and O. Martinez-Maza. 1990. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin-6. Proc. Natl. Acad. Sci. USA 87:4068-4072.
30. Lu, C., and R. S. Kerbel. 1993. Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J. Cell Biol. 120:1281-1288.
31. Chesterman, C. N., T. Walker, B. Grego, K. Chamberlain, M. B. Hearn, and F. J. Morgan. 1983. Comparison of platelet-derived growth factor prepared from release products of fresh platelets and from outdated platelet concentrates. Biochem. Biophys. Res. Commun. 116:809-816.
32. Biondi, A., V. Rossi, R. Bassan, T. Barbui, S. Bettoni, M. Sironi, A. Mantovani, and A. Rambaldi. 1989. Constitutive expression of the interleukin-6 gene in chronic B lymphocytic leukemia. Blood 73:1279-1284.
33. Porgador, A., E. Tzehoval, A. Katz, E. Vadai, M. Revel, M. Feldman, and L. Eisenbach. 1992. Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. Cancer Res. 52: 3679-3686.
34. Wu, C. W., S. R. Wang, M. F. Chao, T. C. Wu, W. Y. Lui, F. K. P'eng, and C. W. Chi. 1996. Serum interleukin-6 levels reflect disease status of gastric cancer. Am. J. Gastroenterol. 91:1417-1422.